Schneider Eugene
EVP, Chf Clinical Develop Ofcr at IONS
- Sold, on record
- $7.9M
- Dollars the filings state
- Form 4 sales
- 14
- Latest Jun 26, 2026
- Form 144 notices
- 14
- Proposed sales
- Quarters with a sale
- 4 of the last 8
- 8 days with a sale in that time
- Companies
- 1
- Filed as an executive or holder
Companies
- IONSIONIS PHARMACEUTICALS INCEVP, Chf Clinical Develop Ofcr
Sales by reason
4
Routine
2
Plan not stated
6
No plan
2
Unusual
Form 4 sales per year, every sale on record.
Timeline
- Jun 26, 2026Unusual
Sold 25.2% of their holdings
$2.1M26,000 shares at $81.05
- Jun 26, 2026Notice
Filed a notice to sell 47,884 shares
$3.9M47,884 shares
- Mar 19, 2026Routine
Sold 8.3% of their holdings
$412k5,812 shares at $70.97
- Mar 19, 2026Notice
Filed a notice to sell 5,812 shares
$412k5,812 shares
- Jan 30, 2026No plan
Sold 8.1% of their holdings
$516k6,179 shares at $83.45
- Jan 30, 2026Notice
Filed a notice to sell 6,179 shares
$513k6,179 shares
- Jan 16, 2026No plan
Sold 12.7% of their holdings
$703k9,302 shares at $75.59
- Jan 16, 2026Notice
Filed a notice to sell 9,302 shares
$709k9,302 shares
- Sep 3, 2025Unusual
Sold 27.6% of their holdings
$1.2M19,658 shares at $60.81
- Sep 3, 2025Notice
Filed a notice to sell 19,658 shares
$1.2M19,658 shares
10 of 28
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Jun 26, 2026 | Jun 30, 2026 | IONS | EVP, Chf Clinical Develop Ofcr | Sold | 26,000 | $81.05 | $2.1M | 77,114 | SEC |
| Jun 26, 2026 | Jun 30, 2026 | IONS | EVP, Chf Clinical Develop Ofcr | Exercised or settledNon-Qualified Stock Option (right to buy) | 26,000 | 26,000 | SEC | ||
| Jun 26, 2026 | Jun 30, 2026 | IONS | EVP, Chf Clinical Develop Ofcr | Exercised options | 26,000 | $60.89 | $1.6M | 103,114 | SEC |
| Mar 19, 2026 | Mar 23, 2026 | IONS | EVP, Chf Clinical Develop Ofcr | Sold | 5,812 | $70.97 | $412k | 63,890 | SEC |
| Jan 30, 2026 | Feb 2, 2026 | IONS | EVP, Chf Clinical Develop Ofcr | Sold | 6,179 | $83.45 | $516k | 69,702 | SEC |
| Jan 29, 2026 | Feb 2, 2026 | IONS | EVP, Chf Clinical Develop Ofcr | Awarded | 11,991 | 75,881 | SEC | ||
| Jan 16, 2026 | Jan 20, 2026 | IONS | EVP, Chf Clinical Develop Ofcr | Sold | 9,302 | $75.59 | $703k | 63,890 | SEC |
| Jan 15, 2026 | Jan 20, 2026 | IONS | EVP, Chf Clinical Develop Ofcr | Exercised or settledRestricted Stock Unit | 21,685 | 39,251 | SEC | ||
| Jan 15, 2026 | Jan 20, 2026 | IONS | EVP, Chf Clinical Develop Ofcr | Exercised options | 21,685 | 73,192 | SEC | ||
| Jan 15, 2026 | Jan 20, 2026 | IONS | EVP, Chf Clinical Develop Ofcr | AwardedPerformance Restricted Stock Units | 35,475 | 48,926 | SEC | ||
| Jan 2, 2026 | Jan 6, 2026 | IONS | EVP, Chf Clinical Develop Ofcr | AwardedNon-Qualified Stock Option (right to buy) | 19,350 | 19,350 | SEC | ||
| Sep 3, 2025 | Sep 4, 2025 | IONS | EVP, Chf Clinical Develop Ofcr | Sold | 19,658 | $60.81 | $1.2M | 51,507 | SEC |
| Sep 3, 2025 | Sep 4, 2025 | IONS | EVP, Chf Clinical Develop Ofcr | Exercised or settledNon-Qualified Stock Option (right to buy) | 19,658 | 0 | SEC | ||
| Sep 3, 2025 | Sep 4, 2025 | IONS | EVP, Chf Clinical Develop Ofcr | Exercised options | 19,658 | $53.77 | $1.1M | 71,165 | SEC |
| Aug 4, 2025 | Aug 5, 2025 | IONS | EVP, Chf Clinical Develop Ofcr | Sold | 9,549 | $42.80 | $409k | 51,507 | SEC |
| Jan 31, 2025 | Feb 3, 2025 | IONS | EVP, Chf Clinical Develop Ofcr | Sold | 1,484 | $32.20 | $48k | 61,056 | SEC |
| Jan 30, 2025 | Feb 3, 2025 | IONS | EVP, Chf Clinical Develop Ofcr | Awarded | 4,032 | 62,540 | SEC | ||
| Jan 16, 2025 | Jan 17, 2025 | IONS | EVP, Chf Clinical Develop Ofcr | Sold | 6,523 | $32.79 | $214k | 58,508 | SEC |
| Jan 15, 2025 | Jan 17, 2025 | IONS | EVP, Chf Clinical Develop Ofcr | Exercised or settledRestricted Stock Unit | 17,372 | 60,936 | SEC | ||
| Jan 15, 2025 | Jan 17, 2025 | IONS | EVP, Chf Clinical Develop Ofcr | Exercised options | 17,372 | 65,031 | SEC | ||
| Jan 15, 2025 | Jan 17, 2025 | IONS | EVP, Chf Clinical Develop Ofcr | AwardedPerformance Restricted Stock Units | 55,000 | 78,308 | SEC | ||
| Jan 2, 2025 | Jan 6, 2025 | IONS | EVP, Chf Clinical Develop Ofcr | AwardedNon-Qualified Stock Option (right to buy) | 22,000 | 22,000 | SEC | ||
| Feb 2, 2024 | Feb 2, 2024 | IONS | EVP, Chf Clinical Develop Ofcr | Sold | 2,071 | $49.59 | $103k | 49,812 | SEC |
| Feb 1, 2024 | Feb 2, 2024 | IONS | EVP, Chf Clinical Develop Ofcr | Awarded | 4,033 | 51,883 | SEC | ||
| Jan 17, 2024 | Jan 18, 2024 | IONS | EVP, Chf Clinical Develop Ofcr | Sold | 5,482 | $50.42 | $276k | 47,850 | SEC |
| Jan 16, 2024 | Jan 18, 2024 | IONS | EVP, Chf Clinical Develop Ofcr | Exercised or settledRestricted Stock Unit | 15,162 | 45,308 | SEC | ||
| Jan 16, 2024 | Jan 18, 2024 | IONS | EVP, Chf Clinical Develop Ofcr | Exercised options | 15,162 | 53,332 | SEC | ||
| Jan 15, 2024 | Jan 17, 2024 | IONS | EVP, Chf Clinical Develop Ofcr | AwardedPerformance Restricted Stock Units | 37,400 | 60,470 | SEC | ||
| Jan 12, 2024 | Jan 17, 2024 | IONS | EVP, Chf Clinical Develop Ofcr | Sold | 8,000 | $53.50 | $428k | 38,170 | SEC |
| Jan 12, 2024 | Jan 17, 2024 | IONS | EVP, Chf Clinical Develop Ofcr | Exercised or settledNon-Qualified Stock Option (right to buy) | 8,000 | 24,265 | SEC | ||
| Jan 12, 2024 | Jan 17, 2024 | IONS | EVP, Chf Clinical Develop Ofcr | Exercised options | 8,000 | $32.60 | $261k | 46,170 | SEC |
| Jan 2, 2024 | Jan 4, 2024 | IONS | EVP, Chf Clinical Develop Ofcr | AwardedNon-Qualified Stock Option (right to buy) | 27,200 | 27,200 | SEC | ||
| Dec 26, 2023 | Dec 28, 2023 | IONS | EVP, Chf Clinical Develop Ofcr | Sold | 25,000 | $51.46 | $1.3M | 36,052 | SEC |
| Dec 26, 2023 | Dec 28, 2023 | IONS | EVP, Chf Clinical Develop Ofcr | Exercised or settledNon-Qualified Stock Option (right to buy) | 25,000 | 0 | SEC | ||
| Dec 26, 2023 | Dec 28, 2023 | IONS | EVP, Chf Clinical Develop Ofcr | Exercised options | 25,000 | $47.34 | $1.2M | 61,052 | SEC |
| Feb 6, 2023 | Feb 7, 2023 | IONS | EVP, Chf Clinical Develop Ofcr | Sold | 1,413 | $40.67 | $57k | 24,946 | SEC |
| Feb 3, 2023 | Feb 7, 2023 | IONS | EVP, Chf Clinical Develop Ofcr | Awarded | 4,033 | 26,359 | SEC | ||
| Jan 18, 2023 | Jan 19, 2023 | IONS | EVP, Chf Clinical Develop Ofcr | Sold | 4,752 | $39.57 | $188k | 22,326 | SEC |
| Jan 17, 2023 | Jan 19, 2023 | IONS | EVP, Chf Clinical Develop Ofcr | Exercised or settledRestricted Stock Unit | 13,046 | 40,070 | SEC | ||
| Jan 17, 2023 | Jan 19, 2023 | IONS | EVP, Chf Clinical Develop Ofcr | Exercised options | 13,046 | 27,078 | SEC | ||
| Jan 15, 2023 | Jan 18, 2023 | IONS | EVP, Chf Clinical Develop Ofcr | AwardedPerformance Restricted Stock Units | 31,545 | 53,116 | SEC | ||
| Jan 3, 2023 | Jan 5, 2023 | IONS | EVP, Chf Clinical Develop Ofcr | AwardedNon-Qualified Stock Option (right to buy) | 22,942 | 22,942 | SEC | ||
| Oct 17, 2022 | Oct 18, 2022 | IONS | EVP, Chf Clinical Develop Ofcr | Exercised or settledRestricted Stock Unit | 416 | 35,909 | SEC | ||
| Oct 17, 2022 | Oct 18, 2022 | IONS | EVP, Chf Clinical Develop Ofcr | Exercised options | 416 | 14,176 | SEC | ||
| Oct 17, 2022 | Oct 18, 2022 | IONS | EVP, Chf Clinical Develop Ofcr | Withheld for tax | 144 | $46.52 | $7k | 14,032 | SEC |
| Jan 18, 2022 | Jan 20, 2022 | IONS | EVP, Chf Clinical Develop Offc | Exercised or settledRestricted Stock Unit | 10,400 | 36,325 | SEC | ||
| Jan 18, 2022 | Jan 20, 2022 | IONS | EVP, Chf Clinical Develop Offc | Exercised options | 10,400 | 17,575 | SEC | ||
| Jan 18, 2022 | Jan 20, 2022 | IONS | EVP, Chf Clinical Develop Offc | Withheld for tax | 3,815 | $30.12 | $115k | 13,760 | SEC |
| Jan 15, 2022 | Jan 19, 2022 | IONS | EVP, Chf Clinical Develop Offc | AwardedPerformance Restricted Stock Units | 28,232 | 46,725 | SEC | ||
| Jan 3, 2022 | Jan 5, 2022 | IONS | EVP, Chf Clinical Develop Offc | AwardedNon-Qualified Stock Option (right to buy) | 32,265 | 32,265 | SEC |
Page 1
Sales and notices (28)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 26, 2026 | Jun 30, 2026 | IONS | EVP, Chf Clinical Develop Ofcr | Form 4 sale | 26,000 | $2.1M | 25.2% | Unusual | SEC |
| Jun 26, 2026 | Jun 26, 2026 | IONS | EVP, Chf Clinical Develop Ofcr | Form 144 notice | 47,884 | $3.9M | Notice | SEC | |
| Mar 19, 2026 | Mar 23, 2026 | IONS | EVP, Chf Clinical Develop Ofcr | Form 4 sale | 5,812 | $412k | 8.3% | Routine | SEC |
| Mar 19, 2026 | Mar 19, 2026 | IONS | EVP, Chf Clinical Develop Ofcr | Form 144 notice | 5,812 | $412k | Notice | SEC | |
| Jan 30, 2026 | Feb 2, 2026 | IONS | EVP, Chf Clinical Develop Ofcr | Form 4 sale | 6,179 | $516k | 8.1% | No plan | SEC |
| Jan 30, 2026 | Jan 30, 2026 | IONS | EVP, Chf Clinical Develop Ofcr | Form 144 notice | 6,179 | $513k | Notice | SEC | |
| Jan 16, 2026 | Jan 20, 2026 | IONS | EVP, Chf Clinical Develop Ofcr | Form 4 sale | 9,302 | $703k | 12.7% | No plan | SEC |
| Jan 16, 2026 | Jan 16, 2026 | IONS | EVP, Chf Clinical Develop Ofcr | Form 144 notice | 9,302 | $709k | Notice | SEC | |
| Sep 3, 2025 | Sep 4, 2025 | IONS | EVP, Chf Clinical Develop Ofcr | Form 4 sale | 19,658 | $1.2M | 27.6% | Unusual | SEC |
| Sep 3, 2025 | Sep 3, 2025 | IONS | EVP, Chf Clinical Develop Ofcr | Form 144 notice | 19,658 | $1.2M | Notice | SEC | |
| Aug 4, 2025 | Aug 5, 2025 | IONS | EVP, Chf Clinical Develop Ofcr | Form 4 sale | 9,549 | $409k | 15.6% | Routine | SEC |
| Aug 4, 2025 | Aug 4, 2025 | IONS | EVP, Chf Clinical Develop Ofcr | Form 144 notice | 9,549 | $409k | Notice | SEC | |
| Jan 31, 2025 | Feb 3, 2025 | IONS | EVP, Chf Clinical Develop Ofcr | Form 4 sale | 1,484 | $48k | 2.4% | No plan | SEC |
| Jan 31, 2025 | Jan 31, 2025 | IONS | EVP, Chf Clinical Develop Ofcr | Form 144 notice | 1,700 | $56k | Notice | SEC | |
| Jan 16, 2025 | Jan 17, 2025 | IONS | EVP, Chf Clinical Develop Ofcr | Form 4 sale | 6,523 | $214k | 10.0% | No plan | SEC |
| Jan 16, 2025 | Jan 16, 2025 | IONS | EVP, Chf Clinical Develop Ofcr | Form 144 notice | 6,523 | $213k | Notice | SEC | |
| Feb 2, 2024 | Feb 2, 2024 | IONS | EVP, Chf Clinical Develop Ofcr | Form 144 notice | 2,071 | $103k | Notice | SEC | |
| Feb 2, 2024 | Feb 2, 2024 | IONS | EVP, Chf Clinical Develop Ofcr | Form 4 sale | 2,071 | $103k | 4.0% | No plan | SEC |
| Jan 17, 2024 | Jan 18, 2024 | IONS | EVP, Chf Clinical Develop Ofcr | Form 4 sale | 5,482 | $276k | 10.3% | No plan | SEC |
| Jan 17, 2024 | Jan 17, 2024 | IONS | EVP, Chf Clinical Develop Ofcr | Form 144 notice | 5,482 | $277k | Notice | SEC | |
| Jan 12, 2024 | Jan 17, 2024 | IONS | EVP, Chf Clinical Develop Ofcr | Form 4 sale | 8,000 | $428k | 17.3% | Routine | SEC |
| Jan 12, 2024 | Jan 12, 2024 | IONS | EVP, Chf Clinical Develop Ofcr | Form 144 notice | 8,000 | $428k | Notice | SEC | |
| Dec 27, 2023 | Dec 27, 2023 | IONS | EVP, Chf Clinical Develop Ofcr | Form 144 notice | 25,000 | $1.3M | Notice | SEC | |
| Dec 26, 2023 | Dec 28, 2023 | IONS | EVP, Chf Clinical Develop Ofcr | Form 4 sale | 25,000 | $1.3M | 40.9% | Routine | SEC |
| Feb 6, 2023 | Feb 7, 2023 | IONS | EVP, Chf Clinical Develop Ofcr | Form 4 sale | 1,413 | $57k | 5.4% | Plan not stated | SEC |
| Feb 6, 2023 | Feb 6, 2023 | IONS | EVP, Chf Clinical Develop Ofcr | Form 144 notice | 1,413 | $57k | Notice | SEC | |
| Jan 18, 2023 | Jan 19, 2023 | IONS | EVP, Chf Clinical Develop Ofcr | Form 4 sale | 4,752 | $188k | 17.5% | Plan not stated | SEC |
| Jan 18, 2023 | Jan 18, 2023 | IONS | EVP, Chf Clinical Develop Ofcr | Form 144 notice | 5,400 | $221k | Notice | SEC |